4//SEC Filing
ONYX PHARMACEUTICALS INC 4
Accession 0001179110-13-011353
CIK 0001012140operating
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:53 PM ET
Size
13.0 KB
Accession
0001179110-13-011353
Insider Transaction Report
Form 4
GODDARD PAUL
Director
Transactions
- Sale
Common Stock
2013-07-01$131.92/sh−3,500$461,703→ 17,390 total - Exercise/Conversion
Common Stock
2013-07-01$28.41/sh+4,000$113,640→ 20,890 total - Sale
Common Stock
2013-07-01$132.63/sh−2,500$331,575→ 14,890 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-07-01−2,000→ 0 totalExercise: $12.50Exp: 2017-02-07→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2013-07-01$12.50/sh+2,000$25,000→ 16,890 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-07-01−4,000→ 1,000 totalExercise: $28.41Exp: 2015-02-07→ Common Stock (4,000 underlying)
Footnotes (3)
- [F1]Shares sold pursuant to 10b5-1 plan.
- [F2]The shares were sold at prices ranging from $131.58 to $132.425. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Fully vested.
Documents
Issuer
ONYX PHARMACEUTICALS INC
CIK 0001012140
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001012140
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 6:53 PM ET
- Size
- 13.0 KB